Orthofix Medical logo

Orthofix MedicalNASDAQ: OFIX

Profile

Sector:

Healthcare

Country:

United States

IPO:

24 April 1992

Next earnings report:

08 August 2024

Last dividends:

N/A

Next dividends:

N/A
$515.28 M
-38%vs. 3y high
67%vs. sector
-vs. 3y high
-vs. sector
-62%vs. 3y high
38%vs. sector
-63%vs. 3y high
17%vs. sector

Price

after hours | Fri, 05 Jul 2024 22:05:44 GMT
$13.73+$0.21(+1.55%)

Dividend

No data over the past 3 years
$188.61 M$195.23 M
$188.61 M-$36.02 M

Analysts recommendations

Institutional Ownership

OFIX Latest News

The Schall Law Firm Starts Scrutiny Of Allegations Against Orthofix Medical Inc And Promotes Investors With Losses To Get Involved
accesswire.com07 July 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Examination Into Accusations Against Orthofix Medical Inc And Encourages Impacted Investors To Engage
accesswire.com05 July 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Inquiry Into Allegations Against Orthofix Medical Inc And Urges Affected Investors To Participate
accesswire.com03 July 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Probe Into Claims Against Orthofix Medical Inc Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Get Involved
accesswire.com02 July 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Probe Into Claims Against Orthofix Medical Inc And Urges Impacted Investors To Get Involved
accesswire.com26 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Starts Probe Into Orthofix Medical Inc And Urges Impacted Investors To Join
accesswire.com25 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Investigation Into Orthofix Medical Inc And Encourages Affected Investors To Participate
accesswire.com24 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Allegations Against Orthofix Medical Inc The Schall Law Firm Begins Investigation And Encourages Affected Investors To Participate
accesswire.com22 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Claims Against Orthofix Medical Inc The Schall Law Firm Starts Probe And Urges Impacted Investors To Get Involved
accesswire.com21 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Investigation Into Allegations Against Orthofix Medical Inc And Encourages Affected Investors To Reach Out
accesswire.com20 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

  • 1(current)
  • 2
  • 3

What type of business is Orthofix Medical?

Orthofix Medical Inc. is a company that specializes in the production of medical equipment, focusing on products and methods for treating the musculoskeletal system. The company's products are represented in segments such as bone growth treatment, spinal implants, biological preparations, and orthopedic devices for limb correction. Orthofix Medical Inc. has two strategic business units: Orthofix Spine (spine treatment) and Orthofix Extremities (limb treatment). Previously known as Orthofix International N.V., the company changed its name to Orthofix Medical Inc. in July 2018. The company was founded in 1987, with its headquarters located in Lewisville, Texas.

What sector is Orthofix Medical in?

Orthofix Medical is in the Healthcare sector

What industry is Orthofix Medical in?

Orthofix Medical is in the Medical Devices industry

What country is Orthofix Medical from?

Orthofix Medical is headquartered in United States

When did Orthofix Medical go public?

Orthofix Medical initial public offering (IPO) was on 24 April 1992

What is Orthofix Medical website?

https://www.orthofix.com

Is Orthofix Medical in the S&P 500?

No, Orthofix Medical is not included in the S&P 500 index

Is Orthofix Medical in the NASDAQ 100?

No, Orthofix Medical is not included in the NASDAQ 100 index

Is Orthofix Medical in the Dow Jones?

No, Orthofix Medical is not included in the Dow Jones index

When does Orthofix Medical report earnings?

The next expected earnings date for Orthofix Medical is 08 August 2024